Literature DB >> 15471370

RANTES: a genetic risk marker for multiple sclerosis.

Radhika Gade-Andavolu1, David E Comings, James MacMurray, Ravi K Vuthoori, Wallace W Tourtellotte, Rashed M Nagra, Lawrence A Cone.   

Abstract

UNLABELLED: Regulated upon activation, normal T-cell expressed and secreted (RANTES) is a beta-chemokine and has been detected in brain lesions of multiple sclerosis (MS) patients. Considering its potential role in MS, we screened two functional polymorphisms in the proximal promoter region of the RANTES in MS patients versus controls.
METHODS: We examined 140 postmortem brain samples from subjects with a primary diagnosis of MS, and peripheral blood samples from 216 control subjects. The RANTES-28C/G and -403G/A promoter polymorphisms were examined. All subjects were non-Hispanic Caucasians.
RESULTS: MS cases differed from controls showing a significant association with the 403G/A polymorphism (odds ratio, 2.359, [1.465-3.799]; P=0.0001), but not the -28C/G (P=NS) polymorphism. There was a significant association of the -28G allele with both early onset (P=0.031) and longer survival (P=0.006).
CONCLUSION: There is a significant but complex association of the RANTES gene with MS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471370     DOI: 10.1191/1352458504ms1080oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

1.  CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro.

Authors:  Eroboghene E Ubogu; Melissa K Callahan; Barbara H Tucky; Richard M Ransohoff
Journal:  Cell Immunol       Date:  2007-01-25       Impact factor: 4.868

2.  A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.

Authors:  Leishangthem Bidyalaxmi Devi; Archana Bhatnagar; Ajay Wanchu; Aman Sharma
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

3.  Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses.

Authors:  Sonali Joshi; Leonidas C Platanias
Journal:  Biomol Concepts       Date:  2012-04

Review 4.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

5.  CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.

Authors:  Lee A Campbell; Valeriya Avdoshina; Summer Rozzi; Italo Mocchetti
Journal:  Brain Behav Immun       Date:  2013-08-19       Impact factor: 7.217

Review 6.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

7.  The Autoimmune Disease Database: a dynamically compiled literature-derived database.

Authors:  Thomas Karopka; Juliane Fluck; Heinz-Theodor Mevissen; Anne Glass
Journal:  BMC Bioinformatics       Date:  2006-06-27       Impact factor: 3.169

8.  Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.

Authors:  Muhammad A Ahad; Tom Missotten; Atiyeh Abdallah; Penny A Lympany; Susan Lightman
Journal:  Mol Vis       Date:  2007-03-23       Impact factor: 2.367

9.  Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  Stephane Steurbaut; Ellen Merckx; Bart Rombaut; Raf Vrijsen
Journal:  Virol J       Date:  2008-08-04       Impact factor: 4.099

10.  RANTES/CCL5 Signaling from Jawbone Cavitations to Epistemology of Multiple Sclerosis - Research and Case Studies.

Authors:  Johann Lechner; Volker von Baehr; Fabian Schick
Journal:  Degener Neurol Neuromuscul Dis       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.